8-K: Select Medical Announces $850 Million Senior Notes Offering to Refinance Debt

Select Medical Holdings Corporation plans to offer $850 million in senior notes to refinance existing debt and amend its credit facilities.

Summary

• Select Medical Corporation, a subsidiary of Select Medical Holdings Corporation, intends to offer $850 million in senior notes due in 2032.
• The proceeds from this offering, along with a new $750 million term loan and existing cash, will be used to repay the current term loan and redeem all outstanding 6.250% senior notes due in 2026.
• The company also plans to amend its existing senior secured credit facilities, including extending the revolving credit facility to five years and adding a $50 million incremental revolving commitment.
• The senior notes will be offered through a private placement to qualified institutional buyers.
• The pro forma financials show a net income attributable to Holdings of $124.2 million for the nine months ended September 30, 2024, and $170.7 million for the year ended December 31, 2023.
• The pro forma adjusted EBITDA was $394.4 million for the nine months ended September 30, 2024, and $446.1 million for the year ended December 31, 2023.
• The company's total debt is estimated at $1.659 billion, with net debt at $1.631 billion as of September 30, 2024.
• The ratio of net debt to pro forma adjusted EBITDA is 3.22x.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the company is taking on new debt, it is for the purpose of refinancing existing obligations and improving its financial structure. The pro forma financials show a reasonable financial position, but there are risks associated with the offering and the broader economic environment.

Positives

• The refinancing will reduce the company's interest expense.
• Extending the revolving credit facility provides more financial flexibility.
• The company is proactively managing its debt obligations.
• The pro forma adjusted EBITDA margin increased from 9.2% to 10.2% for the nine months ended September 30, 2024 compared to the year ended December 31, 2023.

Negatives

• The company is taking on additional debt with the new term loan and senior notes.
• The offering is subject to market conditions and may not be completed as described.
• The company is incurring a loss on early retirement of debt of $35.353 million.
• The company's net income attributable to Holdings decreased from $170.670 million in 2023 to $124.197 million for the nine months ended September 30, 2024.

Risks

• The note offering is subject to market conditions and may not be completed.
• The final terms of the amendments to the credit facilities may vary.
• Changes in government reimbursement policies could reduce revenue and profitability.
• Adverse economic conditions, including inflation, could increase costs.
• Shortages of qualified healthcare professionals could limit the company's ability to staff facilities.
• Public health threats like pandemics could negatively impact patient volumes and revenues.
• Failure to maintain Medicare certifications could cause revenue and profitability to decline.
• Acquisitions or joint ventures may prove difficult or unsuccessful.
• Competition may limit the company's ability to grow.
• Security breaches of information technology systems could lead to legal and reputational harm.

Future Outlook

The company's future performance is subject to various risks and uncertainties, including market conditions, regulatory changes, and economic factors. The company does not intend to review or revise any particular forward-looking statement in light of future events.

Management Comments

• Select Medical intends to use the net proceeds of the offering, together with the proceeds from a new incremental term loan and cash on hand, to repay in full the term loan currently outstanding under its existing credit agreement and to redeem all of its outstanding 6.250% senior notes due 2026.

Industry Context

The healthcare industry is facing challenges such as changing reimbursement policies, rising costs, and labor shortages. This refinancing is a strategic move by Select Medical to manage its debt and improve its financial position in a complex environment.

Comparison to Industry Standards

• HCA Healthcare, a major hospital operator, has a net debt to adjusted EBITDA ratio of around 3.5x, which is slightly higher than Select Medical's 3.22x.
• Tenet Healthcare, another large hospital chain, has a net debt to adjusted EBITDA ratio of approximately 4.5x, indicating Select Medical is less leveraged.
• LifePoint Health, a hospital company, has a net debt to adjusted EBITDA ratio of around 4.0x, again suggesting Select Medical is in a better position.
• The average net debt to EBITDA ratio for healthcare companies is around 3.5x to 4.0x, placing Select Medical in a relatively favorable position compared to its peers.

Stakeholder Impact

• Shareholders may see a positive impact from the reduced interest expense and improved financial structure.
• Employees may not be directly impacted by this transaction.
• Customers and suppliers are unlikely to be directly affected by this financial transaction.
• Creditors will be impacted by the refinancing of existing debt.

Next Steps

• Complete the private placement of the senior notes.
• Finalize the amendments to the senior secured credit facilities.
• Repay the existing term loan and redeem the 6.250% senior notes due 2026.

Key Dates

Keywords

senior notes, refinancing, debt, term loan, credit facility, private placement, healthcare, EBITDA, Select Medical, financial